« Back to Record
Citation APA

Pistone, A., Maerevoet, M., Wittnebel, S., Vercruyssen, M., Spilleboudt, C., Buntinx, S., Bron, D., & Meuleman, N. (2016). Early Discontinuation of Lenalidomide in Patients with Relapsing or Refractory Multiple Myeloma: Predictive Factors for Stopping in the Real Life. Blood, 128(22), 4504-4504. doi:10.1182/blood.V128.22.4504.4504


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/310854

Pistone, A., Maerevoet, M., Wittnebel, S., Vercruyssen, M., Spilleboudt, C., Buntinx, S., Bron, D., & Meuleman, N. (2016). Early Discontinuation of Lenalidomide in Patients with Relapsing or Refractory Multiple Myeloma: Predictive Factors for Stopping in the Real Life. Blood, 128(22), 4504-4504. doi:10.1182/blood.V128.22.4504.4504